Becton Dickinson Insider Tax Withholding: 773 Shares Withheld
Rhea-AI Filing Summary
Michael Feld, EVP & President, Life Sciences at Becton, Dickinson and Company (BDX), reported a non-derivative disposition of 773 shares of BDX common stock on 08/20/2025. The filing uses transaction code F, and the explanatory note states these shares were withheld to satisfy tax withholding upon vesting of previously granted restricted stock units, so the reported price is shown as $0. After the withholding, Mr. Feld beneficially owned 8,417 shares directly. The Form 4 was signed by Donna Kalazdy by power of attorney on 08/22/2025.
Positive
- None.
Negative
- None.
Insights
TL;DR Insider withheld 773 shares for taxes after RSU vesting; small, routine change in holdings.
This Form 4 documents a tax-withholding disposition tied to vesting of previously reported restricted stock units, not an open-market sale or new compensation grant. The reduction of 773 shares to a post-transaction balance of 8,417 shares represents a routine settlement activity that does not change the executive's economic exposure meaningfully. There are no cash proceeds reported and no derivative activity disclosed.
TL;DR Filing reflects standard compliance with Section 16 reporting for RSU tax withholding.
The disclosure is consistent with standard equity compensation practices and shows timely reporting with a power-of-attorney signature. Because the transaction was a withholding for tax obligations, it does not indicate discretionary insider selling or a change in governance. No material governance or control implications are evident from the information provided.
FAQ
What did Michael Feld report on the Form 4 for BDX?
What does transaction code F mean on this Form 4?
How many BDX shares does Michael Feld own after the transaction?
Was any cash consideration reported from the transaction?
Who signed the Form 4 and when?